Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer Journal Article


Authors: Güre, A. O.; Stockert, E.; Scanlan, M. J.; Keresztes, R. S.; Jäger, D.; Altorki, N. K.; Old, L. J.; Chen, Y. T.
Article Title: Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer
Abstract: Serological analysis of expression cDNA libraries (SEREX) derived from two small cell lung cancer (SCLC) cell lines using pooled sera of SCLC patients led to the isolation of 14 genes, including 4 SOX group B genes (SOX1, SOX2, SOX3, and SOX21) and ZIC2. SOX group B genes and ZIC2 encode DNA-binding proteins; SOX group B proteins regulate transcription of target genes in the presence of cofactors, whereas ZIC2 is also suspected to be a transcriptional regulator. These genes are expressed at early developmental stages in the embryonic nervous system, but are down-regulated in the adult. Although SOX2 mRNA can be detected in some adult tissues, ZIC2 is expressed only in brain and testis, and SOX1, SOX3, and SOX21 transcripts are not detectable in normal adult tissues. Of SCLC cell lines tested, 80% expressed ZIC2 mRNA, and SOX1, SOX2, and SOX3 expression was detected in 40%, 50%, and 10%, respectively. SOX group B and ZlC2 antigens elicited serological responses in 30-40% of SCLC patients in this series, at titers up to 1:106. In sera from 23 normal adults, no antibody was detected against SOX group B or ZlC2 proteins except for one individual with low-titer anti-SOX2 antibody. Seroreactivity against SOX1 and 2 was consistently higher titered than SOX3 and 21 reactivity, suggesting SOX1 and/or SOX2 as the main antigens eliciting anti-SOX responses. Although paraneoplastic neurological syndromes have been associated with several SCLC antigens, neurological symptoms have not been observed in patients with anti-SOX or anti-ZlC2 antibodies.
Keywords: adult; controlled study; human tissue; unclassified drug; dna binding protein; human cell; reverse transcription polymerase chain reaction; embryo; lung neoplasms; nerve tissue proteins; tumor cells, cultured; tumor antigen; transcription factors; lung small cell cancer; transcription regulation; amino acid sequence; molecular sequence data; sequence homology, amino acid; antigens, neoplasm; messenger rna; immunogenicity; nucleotide sequence; base sequence; dna primers; paraneoplastic syndrome; humoral immunity; nerve protein; nervous system development; serology; antibodies, neoplasm; antibody titer; northern blotting; carcinoma, small cell; dna library; humans; human; priority journal; article; protein sox; protein zic2
Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Volume: 97
Issue: 8
ISSN: 0027-8424
Publisher: National Academy of Sciences  
Date Published: 2000-04-11
Start Page: 4198
End Page: 4203
Language: English
DOI: 10.1073/pnas.97.8.4198
PUBMED: 10760287
PROVIDER: scopus
PMCID: PMC18195
DOI/URL:
Notes: Export Date: 18 November 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew J Scanlan
    49 Scanlan
  2. Ali O Gure
    29 Gure
  3. Lloyd J Old
    593 Old
  4. Yao-Tseng Chen
    83 Chen